| 4676 | Calamos Strategic Total Return FundCSQ | 🇺🇸 USA | Financial Services | $3.4 B | $-601 M | — | +43.6% |
| — | BlackRock Capital Investment CorporationBKCCUnlisted | 🇺🇸 USA | Financial Services | $285 M (Jan 2024) | $-104 M | — | — |
| — | Mma Capital HoldingsMMACUnlisted | 🇺🇸 USA | Financial Services | $140 M (Jan 2021) | $-11 M | — | — |
| — | MyoKardiaMYOKUnlisted | 🇺🇸 USA | Healthcare | $3.4 B (Jan 2020) | $0 M | — | — |
| 4994 | Denali Therapeutics Inc.DNLI | 🇺🇸 USA | Healthcare | $3.0 B | $0 M | 380 | +7.9% |
| 627 | Revolution Medicines, Inc.RVMD | 🇺🇸 USA | Healthcare | $40.9 B | $0 M | 883 | +791.6% |
| — | Akero Therapeutics, Inc.AKRO | 🇺🇸 USA | Healthcare | $1.3 B (Jan 2024) | $0 M | 34 | — |
| — | SpringWorks Therapeutics, Inc.SWTXUnlisted | 🇺🇸 USA | Healthcare | $2.8 B (Jan 2024) | $0 M | 176 | — |
| 15920 | Zentalis Pharmaceuticals, Inc.ZNTL | 🇺🇸 USA | Healthcare | $217 M | $0 M | 62 | -80.4% |
| 4349 | Amylyx Pharmaceuticals, Inc.AMLX | 🇺🇸 USA | Healthcare | $3.7 B | $0 M | — | +232.3% |
| 15107 | Rocket Pharmaceuticals, Inc.RCKT | 🇺🇸 USA | Healthcare | $274 M | $0 M | 151 | -89.4% |
| 4788 | Viking Therapeutics, Inc.VKTX | 🇺🇸 USA | Healthcare | $3.2 B | $0 M | 18 | +74.0% |
| — | CymaBay Therapeutics, Inc.CBAYUnlisted | 🇺🇸 USA | Healthcare | $2.6 B (Jan 2024) | $0 M | — | — |
| — | 89Bio, Inc.ETNBUnlisted | 🇺🇸 USA | Healthcare | $1.1 B (Jan 2024) | $0 M | — | — |
| — | Piedmont Lithium Inc.PLLUnlisted | 🇺🇸 USA | Basic Materials | $506 M (Jan 2024) | $0 M | — | — |
| 6444 | NextDecade CorporationNEXT | 🇺🇸 USA | Energy | $2.0 B | $0 M | 109 | +64.3% |
| — | Abivax S.A.2X1.F | 🇫🇷 France | Healthcare | $680 M (Jan 2024) | $0 M | — | — |
| — | Lazard Growth Acquisition Corp. ILGACUnlisted | 🇺🇸 USA | Financial Services | $731 M (Jul 2023) | $0 M | — | — |
| 13023 | Allogene Therapeutics, Inc.ALLO | 🇺🇸 USA | Healthcare | $450 M | $0 M | 310 | -21.0% |
| — | Churchill Capital Corp ViCCVI | 🇺🇸 USA | Financial Services | $716 M (Jul 2023) | $0 M | — | — |
| — | Khosla Ventures Acquisition Co. iiiKVSCUnlisted | 🇺🇸 USA | Financial Services | $639 M (Jul 2023) | $0 M | — | — |
| — | Pioneer Merger Corp.PACXUnlisted | 🇺🇸 USA | Financial Services | $513 M (Jul 2023) | $0 M | — | — |
| — | IGM Biosciences, Inc.IGMSUnlisted | 🇺🇸 USA | Healthcare | $506 M (Jan 2024) | $0 M | 51 | — |
| — | Allakos Inc.ALLKUnlisted | 🇺🇸 USA | Healthcare | $239 M (Jan 2024) | $0 M | 192 | — |
| 3395 | Scholar Rock Holding CorporationSRRK | 🇺🇸 USA | Healthcare | $5.4 B | $0 M | 289 | +336.8% |
| — | Icosavax, Inc.ICVXUnlisted | 🇺🇸 USA | Healthcare | $792 M (Jan 2024) | $0 M | 34 | — |
| 17592 | Compass Therapeutics, Inc.CMPX | 🇺🇸 USA | Healthcare | $137 M | $0 M | 39 | -30.9% |
| — | Generation Bio Co.GBIOUnlisted | 🇺🇸 USA | Healthcare | $126 M (Jan 2024) | $0 M | 85 | — |
| — | KalVista Pharmaceuticals, Inc.KALVUnlisted | 🇺🇸 USA | Healthcare | $820 M (Mar 2026) | $0 M | — | — |
| — | Oyster Point PharmaOYSTUnlisted | 🇺🇸 USA | Healthcare | $303 M (Jul 2023) | $0 M | — | — |
| — | scPharmaceuticals Inc.SCPHUnlisted | 🇺🇸 USA | Healthcare | $228 M (Jan 2024) | $0 M | — | — |
| 22308 | BioXcel Therapeutics, Inc.BTAI | 🇺🇸 USA | Healthcare | $37 M | $0 M | 89 | -54.9% |
| 15001 | Fulcrum Therapeutics, Inc.FULC | 🇺🇸 USA | Healthcare | $283 M | $0 M | 104 | -38.3% |
| — | Fusion Pharmaceuticals Inc.FUSNUnlisted | 🇨🇦 Canada | Healthcare | $611 M (Jan 2024) | $0 M | — | — |
| — | LianBio American Depositary SharesLIANUnlisted | 🇺🇸 USA | Healthcare | $451 M (Jan 2024) | $0 M | 107 | — |
| — | Adverum Biotechnologies, Inc.ADVMUnlisted | 🇺🇸 USA | Healthcare | $90 M (Jan 2024) | $0 M | — | — |
| — | Vector Acquisition Corp iiVAQCUnlisted | 🇺🇸 USA | Financial Services | $172 M (Jan 2024) | $0 M | — | — |
| — | Evelo BiosciencesEVLO | 🇺🇸 USA | Healthcare | $1 M (Jan 2024) | $0 M | — | — |
| — | Kezar Life Sciences, Inc.KZRUnlisted | 🇺🇸 USA | Healthcare | $51 M (Mar 2026) | $0 M | 56 | — |
| 13100 | M3-Brigade Acquisition ii Corp.MBAC | 🇺🇸 USA | Financial Services | $442 M | $0 M | — | — |
| — | Poseida Therapeutics, Inc.PSTXUnlisted | 🇺🇸 USA | Healthcare | $308 M (Jan 2024) | $0 M | 263 | — |
| — | Gamida Cell Ltd.GMDAUnlisted | 🇮🇱 Israel | Healthcare | $46 M (Jan 2024) | $0 M | — | — |
| 17590 | American Resources CorporationAREC | 🇺🇸 USA | Basic Materials | $137 M | $0 M | — | +6.1% |
| — | Kinnate Biopharma Inc.KNTEUnlisted | 🇺🇸 USA | Healthcare | $119 M (Jan 2024) | $0 M | 61 | — |
| — | Talaris Therapeutics Inc.TALSUnlisted | 🇺🇸 USA | Healthcare | $131 M (Jul 2023) | $0 M | 82 | — |
| — | Thunder Bridge Capital Partners iii Inc.TBCP | 🇺🇸 USA | Financial Services | $128 M (Jul 2023) | $0 M | — | — |
| 2542 | Praxis Precision Medicines, Inc.PRAX | 🇺🇸 USA | Healthcare | $8.1 B | $0 M | 168 | +3377.3% |
| — | Galera Therapeutics, Inc.GRTXUnlisted | 🇺🇸 USA | Healthcare | $8 M (Jan 2024) | $0 M | — | — |
| 14023 | Capricor Therapeutics, Inc.CAPR | 🇺🇸 USA | Healthcare | $356 M | $0 M | 231 | +118.7% |
| — | Kronos Bio, Inc.KRONUnlisted | 🇺🇸 USA | Healthcare | $71 M (Jan 2024) | $0 M | 45 | — |